T1	Participants 380 452	Participants included 40 outpatient children and adolescents with autism
T2	Participants 715 749	16 patients in the buspirone group
T3	Participants 672 710	Eighteen patients in the placebo group
T4	Participants 1068 1122	Thirteen (81.2%) of 16 patients in the buspirone group
T5	Participants 1127 1172	7 (38.9%) of 18 patients in the placebo group
T6	Participants 1561 1584	individuals with autism
